1. Home
  2. PSQH vs SNTI Comparison

PSQH vs SNTI Comparison

Compare PSQH & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PSQ Holdings Inc.

PSQH

PSQ Holdings Inc.

HOLD

Current Price

$1.07

Market Cap

53.2M

ML Signal

HOLD

Logo Senti Biosciences Inc.

SNTI

Senti Biosciences Inc.

HOLD

Current Price

$1.05

Market Cap

53.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PSQH
SNTI
Founded
2021
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
53.2M
53.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PSQH
SNTI
Price
$1.07
$1.05
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
4
Target Price
$6.00
$9.00
AVG Volume (30 Days)
613.1K
353.3K
Earning Date
11-06-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$27,534,522.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$48.49
$150.00
P/E Ratio
N/A
N/A
Revenue Growth
196.08
N/A
52 Week Low
$0.92
$1.03
52 Week High
$4.99
$5.10

Technical Indicators

Market Signals
Indicator
PSQH
SNTI
Relative Strength Index (RSI) 37.76 35.19
Support Level $1.00 $1.04
Resistance Level $1.34 $1.16
Average True Range (ATR) 0.08 0.06
MACD 0.01 0.02
Stochastic Oscillator 17.88 0.00

Price Performance

Historical Comparison
PSQH
SNTI

About PSQH PSQ Holdings Inc.

PSQ Holdings Inc operates the website and mobile application named as PublicSq. It is an app and website that connects freedom-loving Americans to high-quality businesses that share values, both online and in local communities. It has three reportable segments comprised of Marketplace; which includes a marketplace platform to access consumers that are drawn to patriotic values and the revenue is generated in the form of advertising and eCommerce transactions, and Brands segment in which through its wholly-owned brand, the company generates revenue from online sales of diapers and wipes and third financial technology which assists consumers, lenders, and retailers in offering point-of-sale financing products.

About SNTI Senti Biosciences Inc.

Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.

Share on Social Networks: